These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26562837)

  • 1. Prognostic Role of Adjuvant Chemotherapy in Node-Negative (N0), Triple-Negative (TN), Medullary Breast Cancer (MBC) in the Korean Population.
    Lim S; Park SH; Park HK; Hur MH; Oh SJ; Suh YJ
    PLoS One; 2015; 10(11):e0140208. PubMed ID: 26562837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
    Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
    JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
    Li Y; Zhang N; Zhang H; Yang Q
    J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of immunohistochemically detected p53 in adjuvant chemotherapy-treated triple negative breast cancer.
    Bae SY; Jung SP; Lee SK; Yu J; Lee JE; Kim SW; Nam SJ
    Kaohsiung J Med Sci; 2018 Dec; 34(12):663-672. PubMed ID: 30527200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omission of Chemotherapy for the Treatment of Mucinous Breast Cancer: A Nationwide Study from the Korean Breast Cancer Society.
    Kim HS; Lee JU; Yoo TK; Chae BJ; Son D; Kim YJ; Park WC
    J Breast Cancer; 2019 Dec; 22(4):599-612. PubMed ID: 31897333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base.
    Mateo AM; Pezzi TA; Sundermeyer M; Kelley CA; Klimberg VS; Pezzi CM
    Ann Surg Oncol; 2017 Apr; 24(4):1050-1056. PubMed ID: 27807728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database.
    Du ZL; Wang Y; Wang DY; Zhang L; Bian ZM; Deng Y; Xu CS; Lin DC; Xie L; Jia Y; Gao JD; Zhang BL
    Breast Cancer Res Treat; 2020 Sep; 183(2):429-438. PubMed ID: 32647940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast Cancer.
    Osborne C; Challagalla JD; Eisenbeis CF; Holmes FA; Neubauer MA; Koutrelakos NW; Taboada CA; Vukelja SJ; Wilks ST; Allison MA; Reddy P; Sedlacek S; Wang Y; Asmar L; O'Shaughnessy J
    Clin Breast Cancer; 2018 Feb; 18(1):e89-e95. PubMed ID: 28779904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer.
    Carbajal-Ochoa W; Bravo-Solarte DC; Bernal AM; Anampa JD
    Breast Cancer Res Treat; 2024 Jan; 203(2):257-269. PubMed ID: 37833449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of patients with node-negative, triple-negative breast cancer who benefit from adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy.
    Wu CE; Chen SC; Lin YC; Lo YF; Hsueh S; Chang HK
    Anticancer Res; 2014 Mar; 34(3):1301-6. PubMed ID: 24596377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database.
    Wang XX; Jiang YZ; Liu XY; Li JJ; Song CG; Shao ZM
    Oncotarget; 2016 Apr; 7(16):22665-73. PubMed ID: 27009810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer.
    Leon-Ferre RA; Polley MY; Liu H; Gilbert JA; Cafourek V; Hillman DW; Elkhanany A; Akinhanmi M; Lilyquist J; Thomas A; Negron V; Boughey JC; Liu MC; Ingle JN; Kalari KR; Couch FJ; Visscher DW; Goetz MP
    Breast Cancer Res Treat; 2018 Jan; 167(1):89-99. PubMed ID: 28913760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
    He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
    Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy in small node-negative triple-negative breast cancer.
    Steenbruggen TG; van Werkhoven E; van Ramshorst MS; Dezentjé VO; Kok M; Linn SC; Siesling S; Sonke GS
    Eur J Cancer; 2020 Aug; 135():66-74. PubMed ID: 32554215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients.
    Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Kim S; Choe JH; Lee JE; Kim JH; Kim JS; Nam SJ; Yang JH
    Breast Cancer Res Treat; 2011 Apr; 126(2):471-8. PubMed ID: 21287362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of adjuvant chemotherapy on survival in Korean patients with node negative T1c, triple negative breast cancer.
    Lim ST; Park CH; Kim SY; Nam SJ; Kang EY; Moon BI; Lee HJ; Jeon YW; Gwak H; Suh YJ
    PLoS One; 2018; 13(5):e0197523. PubMed ID: 29768496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials.
    Dieci MV; Mathieu MC; Guarneri V; Conte P; Delaloge S; Andre F; Goubar A
    Ann Oncol; 2015 Aug; 26(8):1698-704. PubMed ID: 25995301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis.
    Yang X; Tang T; Zhou T
    World J Surg Oncol; 2023 Nov; 21(1):364. PubMed ID: 37996840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the adjuvant! Online model to Korean breast cancer patients: an assessment of prognostic accuracy and development of an alternative prognostic tool.
    Jung M; Choi EH; Nam CM; Rha SY; Jeung HC; Lee SH; Yang WI; Roh JK; Chung HC
    Ann Surg Oncol; 2013 Aug; 20(8):2615-24. PubMed ID: 23543197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metaplastic breast cancer: Prognostic and therapeutic considerations.
    Corso G; Frassoni S; Girardi A; De Camilli E; Montagna E; Intra M; Bottiglieri L; Margherita De Scalzi A; Fanianos DM; Magnoni F; Invento A; Toesca A; Conforti F; Bagnardi V; Viale G; Colleoni MA; Veronesi P
    J Surg Oncol; 2021 Jan; 123(1):61-70. PubMed ID: 33047318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.